Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 23;95(24):e01437-21. doi: 10.1128/JVI.01437-21

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 American Society for Microbiology.

All Rights Reserved.

This article is made available via the PMC Open Access Subset for unrestricted noncommercial re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

PMC Copyright notice

FIG 7 — SARS-CoV-2 dose-response curve in MU-UNMC-1 and MU-UNMC-2 treated and SARS-CoV-2 variant of concern infected Calu-3 cells. (A) MU-UNMC-1 dose-response curve by percentage inhibition of SARS-CoV-2 replication 24 hpi in Calu-3 cells infected with South Africa variant (linage: B.1.351) with indicated drug concentrations. (B) MU-UNMC-1 dose-response curve by percentage inhibition of SARS-CoV-2 replication 24 hpi in Calu-3 cells infected with Scotland variant (linage: B.1.222) with indicated drug concentrations. (C) MU-UNMC-2 dose-response curve by percentage inhibition of SARS-CoV-2 replication 24 hpi in Calu-3 cells infected with South Africa variant (linage: B.1.351) with indicated drug concentrations. (D) MU-UNMC-2 dose-response curve by percentage inhibition of SARS-CoV-2 replication 24 hpi in Calu-3 cells infected with Scotland variant (linage: B.1.222) with indicated drug concentrations.